The Anderson Analysis

The children's apparel giant posts strong Q4 sales, but steep tariff impacts and strategic spending lead to a forecast of declining earnings per share.

After a banner 2025, TriMas is selling its aerospace unit to double down on packaging, armed with a major cash infusion and a new efficiency plan.

Kolibri Global Energy Inc. just released its first sustainability report. Is it a genuine shift or a strategic play in a world demanding greener energy?

With $62B in 2025 funding and a 17% surge, Origence is arming credit unions with AI and embedded finance to compete in a rapidly changing market.

With broadband subscribers declining and competition mounting, all eyes are on Co-CEO Mike Cavanagh to outline Comcast's strategy at a key TMT conference.

LSI Industries' acquisition of Royston Group creates a one-stop shop for retail branding, accelerating growth and reshaping the in-store experience.

With $125 million in hand, ClearThink 1 enters a recovering SPAC market, setting its sights on a transformative deal in the dynamic financial services sector.

A new venture plans to transform Los Angeles's legacy oil fields into clean power plants for the AI industry, bypassing an already strained energy grid.

With the appointment of Joey J. Gou, the audio giant signals a strategic overhaul to conquer complex new markets with unparalleled product reliability.

A new giant enters the AI arena. Brookfield launches Radiant to build global 'AI factories,' challenging cloud titans and fueling the race for sovereign AI.

From the founders of thinkorswim, a new AI platform claims you're underpaid by millions and offers tools to prove it. Here's how Lossdog works.

A Singaporean firm debuts an autonomous finishing fleet in North America, promising its 'Physical AI' can solve labor shortages and slash building costs.

Apellis Pharmaceuticals reports its first profitable year on strong SYFOVRE and EMPAVELI sales, but faces pressure to maintain momentum amid competition.

The cannabis giant upsizes its credit facility by CAD $15M, signaling strong lender confidence and fueling its ambitious global expansion plans.

Top veterinary group endorses Visbiome Vet for chronic gut issues, setting a new evidence-based standard in a crowded, unregulated pet supplement market.

An analysis of 880,000 trade setups shows U.S. traders checked liquidation risk twice as often as global peers in 2025, signaling a maturing market.

Compliance Scorecard's v10 introduces audit-ready AI, promising explainable and defensible decisions for MSPs in a tightly regulated market.

EchoStor secures its spot on CRN's Elite 150 list again, fueled by strategic acquisitions, top industry awards, and a focus on complex enterprise IT.

A new initiative offers biotech firms free access to advanced epiproteomic analysis, aiming to accelerate the development of next-generation precision medicines.

The regional bank's latest dividend reflects record earnings and a thriving local economy, making it a stable choice for income-focused investors.